Navigation Links
Rational Design of Modified Release Dosage Forms: From Pharmacokinetic Targets Through Technology Selection, new life science webinar hosted by Xtalks

Toronto, Canada (PRWEB) August 27, 2013

Designing dosage forms that allow for more effective drug delivery and release is critical for success in both the clinic and marketplace.

During this webinar, presenters will discuss a wide array of scalable dosage form technologies available. From tablet and multiparticulate forms to continuous and pulsatile release, esteemed scientists from Bend Research will discuss strategies in dosage design. As well, this webinar will pay particular focus on matching technology strengths with API properties and how to bring the array of choices together through biological modeling.

A Q&A with the presenters, Chris Craig, Director of Dosage Form Product Development, Bend Research, Inc., and Brett Caldwell, Ph.D., Director of Formulation Science, Bend Research, Inc., will follow the main presentation.

For more information about this event or to register, visit:
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

Karen Lim (416) 977-6555 ext 227

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
2. Transportation and Energy Customers Look to Wharfedale’s SAP® Solutions with an Eye toward Cost Savings and Improved Operational Efficiencies
3. Bringing New Cell Therapies to Market Requires Top-Notch Logistics and Operational Efficiency
4. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
5. PharmAthene Reports Year-End 2012 Financial And Operational Results
6. Vet-Stem, Inc. Founder, Robert Harman, DVM, Invited as Inspirational Speaker for the 6th Annual After the Finish Line Charity Dinner
7. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
8. Vote to Help Award a $21,000 AbbVie CF Scholarship to Two Inspirational Students with Cystic Fibrosis Pursuing their Goals of Higher Education
9. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
10. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
11. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. ... (Nasdaq: HART ), a biotechnology company developing bioengineered ... Jim McGorry will present at the LD ... 2015 at 2:30 p.m. PT. The presentation will be ... 30 days. Management will also be available at the ...
(Date:11/25/2015)... ... November 25, 2015 , ... A long-standing partnership between the ... has been formalized with the signing of a Memorandum of Understanding. , AMA ... Capt. Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
Breaking Biology Technology:
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
Breaking Biology News(10 mins):